10:40 AM EST - Willow Biosciences Inc. : Announced today a recap of key milestones the Company has successfully achieved in 2022, as well as its business outlook and key targeted milestones anticipated for 2023 to expand growth. Along with previously announced actions to optimize the business for market success while reducing cash burn and protecting its balance sheet, the Company has continued to successfully execute on its strategic goals and milestones toward year-end 2022. Milestones Achieved During 2022: New cannabigerol downstream process that has been optimized for increased yield and efficiency was fully tech transferred to a large contract manufacturing organization for producing commercial material to sell to existing and new customers; Signed first collaborative deal outside of cannabis for production of a large volume ingredient; Second collaboration announced with Kalsec Inc., a leading global producer of natural taste and sensory, food protection, colours and advanced hops ingredients for the food and beverage industry. Willow Biosciences Inc.
shares T.WLLW are trading up $0.02 at $0.12.
